155 related articles for article (PubMed ID: 38680627)
1. Melanocyte-Keratinocyte Transplantation in Post-Burn Leukoderma Scars: Preliminary Experience Using a Modified Technique.
Louri NA; Dey N; De Sousa RF; AlHasan RN; Abdelhamid MM
Ann Burns Fire Disasters; 2022 Dec; 35(4):306-314. PubMed ID: 38680627
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
3. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of autologous non-cultured melanocyte keratinocyte transplantation in vitiligo and nevus depigmentosus.
Sritanyarat T; Wongpraparut C; Jansuwan N; Yothachai P; Nuntawisuttiwong N; Silpa-Archa N
J Dermatolog Treat; 2022 Mar; 33(2):935-940. PubMed ID: 32643482
[TBL] [Abstract][Full Text] [Related]
5. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
[TBL] [Abstract][Full Text] [Related]
7. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
8. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.
Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV
J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
10. Recipient site preparation by cryoblebbing in melanocyte keratinocyte transplantation procedure over the fingers in vitiligo: A pilot study.
El Hawary M; Bassiouny DA; Esmat S; Sobhi R; Saleh MA; AbdelHalim D; Hegazy R; Gawdat H; Ragab N; Samir N; Sany I
Dermatol Ther; 2020 Nov; 33(6):e14199. PubMed ID: 32798282
[TBL] [Abstract][Full Text] [Related]
11. Subacute cutaneous lupus erythematosus leukoderma treated with melanocyte-keratinocyte transplantation procedure.
Abdo Aguiar LS; Rossini RC; Mesquita LAF; Dellatorre G
J Cosmet Dermatol; 2019 Dec; 18(6):1733-1736. PubMed ID: 30932304
[TBL] [Abstract][Full Text] [Related]
12. Treatment of post-burn leucoderma with non-cultured melanocyte-keratinocyte transplantation (MKTP).
Mulekar SV; Issa AA; Eisa AA
Burns; 2011 May; 37(3):448-52. PubMed ID: 21122997
[TBL] [Abstract][Full Text] [Related]
13. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
[TBL] [Abstract][Full Text] [Related]
14. Nevus depigmentosus treated by melanocyte-keratinocyte transplantation.
Mulekar SV; Al Issa A; Al Eisa A
J Cutan Aesthet Surg; 2011 Jan; 4(1):29-32. PubMed ID: 21572678
[TBL] [Abstract][Full Text] [Related]
15. Noncultured keratinocyte/melanocyte cosuspension: effect on reepithelialization and repigmentation--a randomized, placebo-controlled study.
Back C; Dearman B; Li A; Neild T; Greenwood JE
J Burn Care Res; 2009; 30(3):408-16. PubMed ID: 19349892
[TBL] [Abstract][Full Text] [Related]
16. Practical guidelines for the treatment of vitiligo with the melanocyte-keratinocyte transplantation procedure.
Yousif J; Ceresnie MS; Hamzavi IH; Mohammad TF
Arch Dermatol Res; 2023 Dec; 316(1):10. PubMed ID: 38038734
[TBL] [Abstract][Full Text] [Related]
17. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
19. Studying the effect of adding growth factors to the autologous melanocyte keratinocyte suspension in segmental vitiligo.
Esmat S; Bassiouny D; Saleh MA; AbdelHalim D; Hegazy R; ElHawary M; Gawdat H; Gouda H; Khorshied M; Samir N
Dermatol Ther; 2020 May; 33(3):e13368. PubMed ID: 32243651
[TBL] [Abstract][Full Text] [Related]
20. Postburn leukoderma successfully treated with topical daylight psoralen UVA therapy.
Alzahrani Z; Ghobara YA; AlJasser MI
Dermatol Ther; 2020 Mar; 33(2):e13248. PubMed ID: 32020719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
